Its prediction market now covers FDA approvals and trials, adding a new signal that could sway biotech valuations and trial participation.
Wegovy pill's lead over Foundayo signals drug marketers need to build consumer and healthcare provider brand awareness before launch.
Health advice is the No. 1 reason consumers turn to AI for guidance, putting greater pressure on physicians to correct inaccurate information.
Legal cases over Tylenol use during pregnancy and autism pull Kenvue and retailers back into a fight that could test consumer trust.
Biogen's early stage therapy will prompt health systems and providers to rethink how they care for Alzheimer's patients remotely.
Ingredient removals and limited public details could shape consumer perceptions before investigators reach conclusions.
Almost half (44%) use AI, but limited training and low confidence keep most nurses double-checking outputs, reducing time savings from the tech.
At $184, the mattress industry's cost per action towers roughly 9x above the next-priciest category, home & garden at $20, according to a March report from impact.com.
Without upfront cost estimates and early financial guidance, patients are making tough financial trade-offs.
Women expect more access and easier navigation of what’s already available.
This reflects healthcare’s broader expansion into sports marketing as brands seek to connect with younger, diverse audiences.
The warehouse club partners with Weight Watchers to expand its wellness bundle.
Google's AI Mode healthcare ad test signals expanding AI ad inventory, though disclosure-heavy healthcare ads remain excluded for now.
But many doctors aren’t convinced that wearable-generated health data has enough clinical value to influence their decisions.
Young adults piece together care through urgent care, telehealth, and apps, challenging primary care providers to rethink engagement strategies.
New Trump proposal to require full safety disclosures in TV and radio prescription drug ads could face legal challenges but still accelerate pharma marketers' shift to digital.
Tools and home improvement delivered the strongest ad returns of any industry at $4.56 for every dollar spent in Q4 2025, nearly 2.5x the return clothing, shoes & jewelry advertisers saw ($1.86), according to a Q4 2025 report from SellMetric.
Many telehealth sites skipped key check-ins with patients yet still prescribed GLP-1s, inviting regulatory scrutiny.
Food companies race to adapt as millions rethink what—and how much—they eat.
Adults 18–34 rate in-office digital and print health information higher than other generations, debunking assumptions that older generations are target audiences.